U S PHYSICAL THERAPY INC /NV Business Combination, Contingent Consideration, Liability
U S PHYSICAL THERAPY INC /NV (USPH) had Business Combination, Contingent Consideration, Liability of $1.50 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2026-08-07
- 2026-06-30: Business Combination, Contingent Consideration, Liability $1.50M.
- 2026-03-31: Business Combination, Contingent Consideration, Liability $5.80M.
- 2025-12-31: Business Combination, Contingent Consideration, Liability $12.30M.
- 2025-09-30: Business Combination, Contingent Consideration, Liability $9.60M.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2026-06-30 | $1.50M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $5.80M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $12.30M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $9.60M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $14.80M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $14.00M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $17.60M 10-K · filed 2026-02-27 |
| 2024-09-30 | $22.70M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $17.20M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $10.80M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $9.80M 10-K · filed 2025-03-03 |
| 2022-12-31 | $8.30M 10-K · filed 2024-02-29 |
| 2021-12-31 | $3.50M 10-K · filed 2023-02-28 |
| 2021-09-30 | $900.00K 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |